Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RRM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SIVA1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FST - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NMT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DCTN5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CHCHD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TMEM97 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPAG11A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIOS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
TIAL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CHST3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBM10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ICMT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CXXC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RRM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADCK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IDI1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DNAJC9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NKX2-1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on